The Business & Financial Times on MSN
Coronation Insurance launches ‘Pay-As-You-Earn’ motor insurance
By Desmond MASOPEHCoronation Insurance Ghana Limited has launched a new “Pay-As-You-Earn” motor insurance, a flexible payment solution that allows motorists to buy their insurance on monthly, ...
14hon MSN
Herof 2.0 explained: Balochistan is exploding again - and why it matters for Pakistan and world
Pakistan faces a deepening security crisis in Balochistan as the Baloch Liberation Army escalates its campaign through "Operation Herof. This surge impacts Pakistan's economy, foreign relations, and ...
'Announcement signals strong political will': Industry experts, politicians laud India-US trade deal
Leaders and industry experts welcome the landmark deal, which cuts tariffs on Indian goods, boosts Make in India initiatives, ...
Researchers from The Ohio State University and the Indian Institute of Technology Madras have developed an artificial ...
New treatments based on biological molecules like RNA give scientists unprecedented control over how cells function. But ...
Zacks Investment Research on MSN
Ultragenyx Pharmaceutical resubmits UX111 BLA for Sanfilippo syndrome
Ultragenyx Pharmaceutical RARE announced the resubmission of its biologics license application (“BLA”) to the FDA seeking ...
The FDA approved Yuvezzi, a fixed-dose combination eye drop of carbachol and brimonidine tartrate, for the treatment of presbyopia in adult patients.
The agency previously declined to approve the application for UX111, citing issues related to chemistry, manufacturing, and controls (CMC).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results